<!--
**cetienn01/cetienn01** is a  _special_  repository because its `README.md` (this file) appears on your GitHub profile.
-->

### Hi there! ğŸ‘‹ğŸ¿
âœ¨ I'm **Chris** âœ¨ . I am **multidisciplinary** scientist working at the intersection of **`Biology`** ğŸ§« , **`Chemistry`** âš—ï¸, and **`Data Science`** ğŸ‘¨ğŸ¿â€ğŸ’»

- ğŸ— Iâ€™m currently working on identifying novel **Targets** ğŸ¯ and **Biomarkers** in **Hematological Malignancies** and **Solid Tumors**
- ğŸ”­ Iâ€™m currently learning more about **AI** ğŸš€ with a focus on **Deep Learning** and **Machine Learning** ğŸ¤–
- ğŸ’­ Ask me about **Immunology** ğŸ§¬, **Oncology**ğŸ”¬ and **Chemical Biology**
- ğŸ¤ Iâ€™m looking to collaborate on interesting **Bioinformatics** or **Cheminformatics** research projects
- ğŸ¤” Iâ€™m thinking about novel approaches to **Drug Discovery** ğŸ’Š and **Targeted Therapy** âš¡
- I am passionate about **STEM Education** ğŸ“š and **Social Justice** ğŸ’¡
- ğŸ“«  You can connect with me directly at one of the platforms below :

[![Twitter](https://img.shields.io/twitter/url?label=Twitter&style=social&url=https%3A%2F%2Ftwitter.com%2Fiamchrisetienne)](https://twitter.com/iamchrisetienne)
[![LinkedIn](http://img.shields.io/badge/LinkedIn-blue?style=flat&logo=linkedin)](https://www.linkedin.com/in/christian-etienne/)
[![Medium](https://img.shields.io/badge/Medium-black?style=flatl&logo=medium)](https://medium.com/@cetienn01)
[![Gmail](https://img.shields.io/badge/Gmail-red?style=flat&logo=Gmail&labelColor=white&link=mailto:cetienn01@gmail.com)](mailto:cetienn01@gmail.com)
[![Github](https://img.shields.io/badge/GitHub-000?style=flat&logo=Github&labelColor=white&logoColor=Black)](https://github.com/cetienn01)

### Computational Research Interests
- developing novel bioinformatics tools to investigate high-throughput genomics data to understand the mechanisms of diseases, with a particular interest in cancer
- applying computational methods to study biological processes such as protein-protein interaction and protein-ligand binding to design the next generation of cell permeable and orally bioavailable macrocyclic drugs.
- implementing machine learning algorithms to support classification and prediction of clinical outcomes using molecular features
